FIELD: medicine.
SUBSTANCE: method involves determining relative CD38+ lymphocytes content in peripheral blood. The value being greater than 23%, rapid myoma uteri growth during the year.
EFFECT: high accuracy specificity and sensitivity of prognosis method.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF QUICKLY METASTASING UTERINE LEIOMYOMA | 2003 |
|
RU2258222C2 |
| METHOD OF PREDICTING OF FAST GROWTH OF LEIOMYOMA OF UTERUS | 2007 |
|
RU2340897C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704817C1 |
| METHOD OF DETECTING HEREDITARY PREDISPOSITION TO FAST GROWTH OF UTERINE MYOMA | 2011 |
|
RU2475740C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704819C1 |
| METHOD FOR PREDICTING GROWTH RATE OF UTERINE LEIOMYOMA IN WOMEN OF REPRODUCTIVE AGE | 2018 |
|
RU2690379C1 |
| METHOD FOR DIAGNOSING PROLIFERATIVE ACTIVITY OF UTERINE LEIOMYOMA CELLS | 2019 |
|
RU2700003C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF LEIOMYOMA GROWTH PATTERNS | 2013 |
|
RU2542468C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR UTERUS LEIOMYOMA GROWTH TYPE | 2008 |
|
RU2361216C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF DEVELOPMENT OF PROLIFERATING UTERUS MYOMA | 2018 |
|
RU2676035C1 |
